scholarly journals EED, a member of the polycomb group, is required for nephron differentiation and the maintenance of nephron progenitor cells

Development ◽  
2018 ◽  
Vol 145 (14) ◽  
pp. dev157149 ◽  
Author(s):  
Le Zhang ◽  
Sandrine Ettou ◽  
Myda Khalid ◽  
Mary Taglienti ◽  
Dhawal Jain ◽  
...  

Blood ◽  
2010 ◽  
Vol 116 (15) ◽  
pp. 2812-2821 ◽  
Author(s):  
Fabiana Perna ◽  
Nadia Gurvich ◽  
Ruben Hoya-Arias ◽  
Omar Abdel-Wahab ◽  
Ross L. Levine ◽  
...  

Abstract L3MBTL1, the human homolog of the Drosophila L(3)MBT polycomb group tumor suppressor gene, is located on chromosome 20q12, within the common deleted region identified in patients with 20q deletion-associated polycythemia vera, myelodysplastic syndrome, and acute myeloid leukemia. L3MBTL1 is expressed within hematopoietic CD34+ cells; thus, it may contribute to the pathogenesis of these disorders. To define its role in hematopoiesis, we knocked down L3MBTL1 expression in primary hematopoietic stem/progenitor (ie, CD34+) cells isolated from human cord blood (using short hairpin RNAs) and observed an enhanced commitment to and acceleration of erythroid differentiation. Consistent with this effect, overexpression of L3MBTL1 in primary hematopoietic CD34+ cells as well as in 20q− cell lines restricted erythroid differentiation. Furthermore, L3MBTL1 levels decrease during hemin-induced erythroid differentiation or erythropoietin exposure, suggesting a specific role for L3MBTL1 down-regulation in enforcing cell fate decisions toward the erythroid lineage. Indeed, L3MBTL1 knockdown enhanced the sensitivity of hematopoietic stem/progenitor cells to erythropoietin (Epo), with increased Epo-induced phosphorylation of STAT5, AKT, and MAPK as well as detectable phosphorylation in the absence of Epo. Our data suggest that haploinsufficiency of L3MBTL1 contributes to some (20q−) myeloproliferative neoplasms, especially polycythemia vera, by promoting erythroid differentiation.



2015 ◽  
Vol 34 (2) ◽  
pp. 229-241 ◽  
Author(s):  
Aaron C. Brown ◽  
Sree Deepthi Muthukrishnan ◽  
Leif Oxburgh


2017 ◽  
Vol 28 (11) ◽  
pp. 3133-3135
Author(s):  
Leif Oxburgh ◽  
Clifford J. Rosen


eLife ◽  
2021 ◽  
Vol 10 ◽  
Author(s):  
Qiuyu Guo ◽  
Albert D Kim ◽  
Bin Li ◽  
Andrew Ransick ◽  
Helena Bugacov ◽  
...  


Author(s):  
Masaki Nishikawa ◽  
Shunsuke Yuri ◽  
Hiroshi Kimura ◽  
Naomi Yanagawa ◽  
Morgan Hamon ◽  
...  


2018 ◽  
Vol 6 (7) ◽  
pp. e13644 ◽  
Author(s):  
Renfang Song ◽  
Laura Kidd ◽  
Adam Janssen ◽  
Ihor V. Yosypiv


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Aleksandra Cwiek ◽  
Masako Suzuki ◽  
Kimberly deRonde ◽  
Mark Conaway ◽  
Kevin M. Bennett ◽  
...  

AbstractPreterm birth is a leading cause of neonatal morbidity. Survivors have a greater risk for kidney dysfunction and hypertension. Little is known about the molecular changes that occur in the kidney of individuals born preterm. Here, we demonstrate that mice delivered two days prior to full term gestation undergo premature cessation of nephrogenesis, resulting in a lower glomerular density. Kidneys from preterm and term groups exhibited differences in gene expression profiles at 20- and 27-days post-conception, including significant differences in the expression of fat-soluble vitamin-related genes. Kidneys of the preterm mice exhibited decreased proportions of endothelial cells and a lower expression of genes promoting angiogenesis compared to the term group. Kidneys from the preterm mice also had altered nephron progenitor subpopulations, early Six2 depletion, and altered Jag1 expression in the nephrogenic zone, consistent with premature differentiation of nephron progenitor cells. In conclusion, preterm birth alone was sufficient to shorten the duration of nephrogenesis and cause premature differentiation of nephron progenitor cells. These candidate genes and pathways may provide targets to improve kidney health in preterm infants.



Author(s):  
Raphael Kopan ◽  
Shuang Chen ◽  
Melissa Little


Sign in / Sign up

Export Citation Format

Share Document